These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4472899)

  • 21. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duration of circulating and secretory antibody and cell-mediated immunity following immunization.
    Waldman RH; Ganguly R
    Dev Biol Stand; 1975; 28():273-84. PubMed ID: 1126572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rubella antibody titres and immunization status in a family practice.
    Mills DA; Parker KR; Evans CE
    Can Med Assoc J; 1980 Mar; 122(5):549-52. PubMed ID: 7370858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of bilirubin on cellular immune responses in man.
    Rola-Plezczynski M; Hensen SA; Vincent MM; Bellanti JA
    J Pediatr; 1975 May; 86(5):690-6. PubMed ID: 124327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined live rubella-mumps virus vaccine. Findings in clinical-laboratory studies.
    Weibel RE; Stokes J; Villarejos VM; Arguedas JA; Buynak EB; Hilleman MR
    JAMA; 1971 May; 216(6):983-6. PubMed ID: 5108387
    [No Abstract]   [Full Text] [Related]  

  • 26. Complement-fixing and fluorescent antibody responses to an attenuated Rubella virus vaccine.
    Schmidt NJ; Lennette EH
    Am J Epidemiol; 1970 Apr; 91(4):351-4. PubMed ID: 4912184
    [No Abstract]   [Full Text] [Related]  

  • 27. Presensitization and clinical kidney transplantation. II. Correlative studies of humoral and cellular immunity and clinical course.
    Myburgh JA; Maier G; Smit JA; Shapiro M; Meyers AM; Rabkin R; Van Blerk PJ; Jersky J
    Transplantation; 1974 Sep; 18(3):213-22. PubMed ID: 4607999
    [No Abstract]   [Full Text] [Related]  

  • 28. A controlled family study of live, attenuated rubella-virus vaccine.
    Lefkowitz LB; Rafajko RR; Federspiel CF; Quinn RW
    N Engl J Med; 1970 Jul; 283(5):229-32. PubMed ID: 4912790
    [No Abstract]   [Full Text] [Related]  

  • 29. [Test of anti-rubella vaccination with live and attenuated virus (Cendehill strain)].
    Leogrande G; Barnaba L; Iandolo E; Iatta E
    Minerva Med; 1970 Apr; 61(30 Suppl):1595-8. PubMed ID: 4378365
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the allospecific and viral-specific immune responses to irradiated versus formaldehyde-fixed allogeneic Moloney lymphoma cells in CBA mice.
    Lamon EW; Gatti RA; Kiessling R; Fenyö EM
    Cancer Res; 1975 Apr; 35(4):962-9. PubMed ID: 1090367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of cell-mediated immunity to measles virus by in vitro lymphocyte-mediated cytotoxicity.
    Labowskie R; Edelman R; Rustigian R; Bellanti JA
    J Infect Dis; 1974 Mar; 129(3):233-9. PubMed ID: 4816303
    [No Abstract]   [Full Text] [Related]  

  • 32. The immunoglobulin response to reimmunization with rubella vaccine.
    Scott RM; Schydlower M; Lampe RM; Schwab JA; Muelenaer AA
    J Pediatr; 1981 Oct; 99(4):531-4. PubMed ID: 7277092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serological assay of measles and rubella immunity in a sample of infantile population in palermo (author's transl)].
    Arista S; Ammatuna P; Leggio M; Chiarini A
    Ann Sclavo; 1980; 22(1):42-8. PubMed ID: 7247483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. I. Specificity and kinetics.
    Gardner I; Bowern NA; Blanden RV
    Eur J Immunol; 1974 Feb; 4(2):63-7. PubMed ID: 4211857
    [No Abstract]   [Full Text] [Related]  

  • 35. Guide to the management of rubella problems.
    Middleton PJ; Larke RP; Lessard P; Doran TA
    Can Med Assoc J; 1977 Mar; 116(5):484-8. PubMed ID: 837313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated and humoral immune responses to BCG and rubella vaccinations and to recall antigens in onchocerciasis patients.
    Kilian HD; Nielsen G
    Trop Med Parasitol; 1989 Dec; 40(4):445-53. PubMed ID: 2623427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon production in lymphocyte cultures after rubella infection in humans.
    Buimovici-Klein E; Weiss KE; Cooper LZ
    J Infect Dis; 1977 Mar; 135(3):380-5. PubMed ID: 850076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence of Immunity Acquired after a Single Dose of Rubella Vaccine in Japan.
    Okafuji T; Okafuji T; Nakayama T
    Jpn J Infect Dis; 2016 May; 69(3):221-3. PubMed ID: 26255735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the cell population involved in viral-specific cell-mediated cytotoxicity in man: evidence for T cell specificity.
    Rola-Pleszczynski M; Hurtado RC; Woody JN; Sell KW; Vincent MM; Hensen SA; Bellanti JA
    J Immunol; 1975 Jul; 115(1):239-42. PubMed ID: 50349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Level of antibodies against rubella in the normal population of Nanning city and a survey of the immunizing efficacy of rubella live-vaccines].
    Chen J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Feb; 6(1):12-4. PubMed ID: 3995568
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.